Genomtec S.A. Logo

Genomtec S.A.

GMT | WAR

Overview

Corporate Details

ISIN(s):
PLGNMTC00017
LEI:
259400ND13Y44ADMG554
Country:
Poland
Address:
WROCŁAW BIERUTOWSKA 57-59, 51-317 WROCŁAW
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genomtec S.A. is a medical technology company specializing in the research, development, and commercialization of innovative molecular diagnostic solutions. The company's flagship product is the Genomtec ID, a mobile platform designed for rapid and precise genetic diagnostics at the point-of-care. Its core technology is based on proprietary isothermal nucleic acid amplification methods. A key commercialized product is the CE-IVD certified GenomtecID Respiratory Panel 5-Plex, which detects viruses and bacteria responsible for respiratory tract infections. The company is also advancing its OncoSNAAT project in the field of genomics.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Genomtec S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 17:28
Share Issue/Capital Change
Przyznanie akcji w ramach warunkowego podwyższenia kapitału zakładowego - Conte…
Polish 2.2 KB
2025-08-01 15:26
Regulatory News Service
Otrzymanie od Urzędu Patentowego w Japonii decyzji o udzieleniu ochrony patento…
Polish 1.7 KB
2025-07-31 10:13
Board/Management Information
Powołanie nowego Członka Zarządu GENOMTEC S.A. - Content (PL)
Polish 2.7 KB
2025-07-11 20:04
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
Polish 1.0 KB
2025-07-11 20:00
Post-Annual General Meeting Information
zal01_GENOMTEC_ESPI_32_2025_Zalacznik..pdf
Polish 129.4 KB
2025-07-11 20:00
Post-Annual General Meeting Information
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Genomtec S.A. w dn…
Polish 627 bytes
2025-06-13 18:00
Post-Annual General Meeting Information
zal02_2._Projekty_uchwal_NWZ_13.06.2025.pdf
Polish 144.5 KB
2025-06-13 18:00
Pre-Annual General Meeting Information
zal01_1._Ogloszenie_o_zwolaniu_NWZ.pdf
Polish 185.9 KB
2025-06-13 18:00
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Genomtec S.A. na dzień 11 lipca 20…
Polish 1.6 KB
2025-06-06 07:21
Post-Annual General Meeting Information
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 1.7 KB
2025-06-06 07:18
Post-Annual General Meeting Information
zal01_GENOMTEC_ESPI_29_2025_Uchway_ZWZ_Zalacznik..pdf
Polish 550.6 KB
2025-06-06 07:18
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie Genomtec S.A. …
Polish 625 bytes
2025-05-29 17:25
Quarterly Report
zal02_Pozostale_informacje_do_raportu_za_1Q2025.pdf
Polish 842.1 KB
2025-05-29 17:25
Quarterly Report
zal01_spr_I_Q_2025.pdf
Polish 166.4 KB
2025-05-23 15:12
Remuneration Information
zal01_GENOMTEC_UA2024_Raport_z_wykonanej_uslugi_ost.pdf
Polish 391.8 KB

Automate Your Workflow. Get a real-time feed of all Genomtec S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genomtec S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Specialty vaccine developer for travelers and infectious diseases like chikungunya.
France VLA
VENTURE LIFE GROUP PLC Logo
Develops and distributes consumer self-care products for the ageing population worldwide.
United Kingdom VLG
Vetoquinol SA Logo
Develops and distributes veterinary drugs and products for livestock and companion animals globally.
France VETO
Vifor Pharma AG Logo
Develops iron-based pharmaceuticals for iron deficiency, nephrology, and rare diseases.
Switzerland VIFN
Virbac Logo
A pharmaceutical company developing animal health solutions for vets, farmers, and pet owners worldwide.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin API for the international pharmaceutical industry.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V